Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction

Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction

Aim. To study changes in myocardial contractile function when prescribing mineralocorticoid receptor antagonists of spironolactone in patients after coronavirus infection SARS-CoV-2 with symptoms of chronic heart failure (CHF).Materials and methods. The study included 90 hospitalized patients with a...

Full description

Saved in:
Bibliographic Details
Main Authors: V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva
Format: Article
Language:English
Published: Столичная издательская компания 2022-05-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
coronavirus infection
covid-19
spironolactone
chronic heart failure
Online Access:https://www.rpcardio.online/jour/article/view/2712
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items